Life Sciences
Clinical DevelopmentRecruit and retain verified participantsReal-World EvidenceConsented data for studies and HEORAccess & SupportFaster onboarding for patient programsHelp patients start therapy faster and stay on it.
Give your patient support and market access teams the complete patient record, with consent captured in seconds, to clear access hurdles and keep patients on therapy.
Request a demo
Prescribed isn’t started. Started isn’t adherent.
The full record for access. A direct line for support.
01
Fast, digital consent
Patients enroll and authorize in under 60 seconds, with no paperwork.
02
Complete records for access
Clinical notes, labs, imaging, pharmacy, and insurance data to support benefits verification and prior authorization.
03
Prior auth evidence, surfaced instantly
AllClear Guide reads the full record and pulls out what payers ask for, including diagnosis, prior therapies, and lab values.
04
Ongoing engagement
A direct, consented line to patients for adherence support, refills, and program updates.
05
Flexible integration
Connect via portal, API, or MCP, alongside your existing hub and CRM tools.
06
AVAILABLE ADD-ON
Co-branded patient app
Upgrade to a patient app that carries your program or therapy brand, powered by AllClear.
More patients on therapy. More patients staying on it.
01
Faster time to therapy
Complete records arrive without the fax-and-phone chase, so benefits verification and prior authorization move sooner.
02
Easier onboarding, personalized from day one
Verified identity turns unknown patients into known ones, so support can be personalized the moment they enroll.
03
A direct line for long-term support
Reach patients before a prescription goes unfilled, then keep them engaged with refills and program resources for better outcomes.
And it compounds. The same patient connections support real-world evidence and future trial recruitment.
“Real-time, two-way patient communications channels make proactive drug adherence intervention possible at scale, targeting 60–80% participation, instead of accepting single digits as the norm.”
Drew Isaacs · Former VP of Marketing Operations, Novartis